India pharma giants and global big pharma join forces for NMEs commercialisation in India:…
The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Rituximab
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL
Data from Phase 3 E1912 study showed previously untreated patients aged 70 years or younger treated with ibrutinib plus rituximab…
Torrent Pharma in agreement with Reliance Life Sciences
Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of…